TRANSFORMING FRACTURE RISK
ASSESSMENT FOR CANCER PATIENTS
WITH VERTEBRAL METASTASES
Computer-aided effective fracture risk stratification of patients with vertebral metastases for personalised treatment through robust computational models validated in clinical settings

FRONTENDART: Transforming Fracture Risk Assessment for Cancer Patients with Vertebral Metastases

FRONTENDART: Transforming Fracture Risk Assessment for Cancer Patients with Vertebral Metastases

A groundbreaking initiative, METASTRA, is set to transform the way clinicians assess fracture risk in cancer patients with vertebral metastases. The ambitious project funded by the EU’s Horizon Europe “Tools and technologies for a healthy society„ Calls promises to provide personalised treatment recommendations based on robust computational models and improved patient stratification techniques. Coordinated by the University of Bologna, METASTRA brings together 15 partners from different European Member States, receiving a total funding of 6.7 Mil EUR over the next five years. With an avid and visionary work plan, the international, multidisciplinary research team is poised to make a substantial impact on the lives of cancer patients and the healthcare system as a whole.

Read the full article here.